Miromatrix is a biotechnology company bioengineering transplantable organs to eliminate the organ transplant waiting list, including livers, kidneys, and lungs based on its patented perfusion decellularization and recellularization technologies. Our approach has the potential to access billion-dollar market opportunities and our progress to date were recently recognized by winning a KidneyX prize from the Department of Health and Human Services (HHS) and being named Buzz of BIO for Pipelines of Promise. Pipelines of Promise.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Liver and Kidney
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):